The good news brought by Wen Renlong made Wei Kang feel refreshed and overjoyed.

After squeezing the system's wool for so long, an outstanding talent who can independently innovate and develop new drugs has finally emerged. All along, he has been selling prescriptions from the system for money. With so many employees under him, he can develop innovative drugs.

There are very few.

Of course, this is also related to the fact that the rise of Sanqing was too short, and the accumulation of talents also requires a process.

Fortunately, after he invested a lot of money, he finally started to get rich returns.

It started as a biological laboratory. In the field of single-gene genetic diseases, it made full use of the al software and developed many genetic drugs, which gave him a big surprise.

But this is more of a breakthrough in clinical application based on existing theoretical foundations.

After all, the basic genome theory and gene editing software come from others, and only the al pharmaceutical software is Sanqing's own.

Wei Kang is not satisfied with this. He provides so many resources and does not just want some ready-made things.

On this basis, he wanted to draw inferences from one example, bring forth new ideas from the old, and make discoveries and breakthroughs in basic theory.

The development process of anticoagulants illustrates this point well.

Based on an in-depth study of an existing drug, we discovered the principle of its action, and then reverse-innovated, continuously screened out suitable compound molecules, and finally successfully developed a new drug.

This is a perfect innovative drug research and development process.

Employees who can achieve this step will be able to continue to explore new fields and develop new drugs even if there is no continuous supply of drugs in the future.

Such employees did not exist in Sanqing before, and it is impossible to exist in most domestic pharmaceutical companies that do not pay attention to research and development. Otherwise, there would be no story of his continuous failure to develop new drugs before he obtained the system.

However, Sanqing is now available.

With the ability to continue R&D and innovation.

This is a symbol of the R&D capabilities of pharmaceutical companies and is also the basis for a company to be based on the market.

This is why he is so happy.

Sanqing has slowly transformed from a black technology enterprise that adopted the doctrine into a high-tech enterprise with independent technology. You must know that everything taken from the system is black technology, just like black boxes.

Only by slowly opening it and studying it thoroughly from the inside out can you peel off the cloak of black technology and turn it into your own high technology.

Black technology is a well-known technology that is useful to humans, but its effect is not as great as imagined.

Technology that is extracted from the black technology box and thoroughly absorbed is high technology that knows its origin and can trigger scientific and technological breakthroughs that span the ages.

This is Wei Kang’s long-term strategy of squeezing out the system.

At present, this strategy has been implemented very successfully and has produced rich output.

If this continues, Sanqing Group will surely be able to develop new technologies that are entirely of its own, and may even make breakthroughs in theoretical science, thereby truly entering a new era of biology.

After thinking about it, he set his sights again on the remaining five innovative drugs.

Antihypertensive drugs and antithrombotic drugs have been handed over to Wen Renlong. For scar removal cream and hair removal cream, just ask the laboratory employees to contact cr0 company for the second phase of clinical trials. As long as the clinical report is released, it should be easy.

Coming soon.

Insecticides are pesticides and must undergo toxicology and safety assessments, as well as field efficacy tests before they can be approved by the agricultural department.

This aspect is a new business, and it is estimated that not many people in Sanqing Pharmaceutical are familiar with it, so it can only be handed over to CR0 Company.

"Pet medicine? This Chen Yiqing seems to be very interested. We can put him in charge of this project."

Wei Kang thought for a moment and called Chen Yiqing over.

When Chen Yiqing saw the special medicine passed down from the cat's belly in his hand, his eyes suddenly lit up and his face suddenly became happy.

"Mr. Wei, is this project assigned to me? Great, this is exactly the new project I have dreamed of.

Wei Kang looked at his excited expression and couldn't help but twitch the corner of his mouth.

He asked jokingly: "What? Dr. Chen, neuroscience is no longer your favorite?"

"Are you planning to work part-time as director of the animal health laboratory?"

Chen Yiqing was overjoyed and said: "Is the company going to establish a new animal health laboratory? Then I am very honored to be able to serve as the director.

Wei Kang was speechless. He shook his head and said, "This is just a new drug. It's not yet time to set up a new laboratory. Let's wait until Sanqing's pet drug is developed.'

Chen Yiqing laughed and said, "I think so."

"Okay, you can be responsible for this project. If you need anything, just contact cro and find a pet hospital to do animal clinical experiments."

Wei Kang waved his hand and sent Chen Yiqing away.

He thought for a while, then called his old subordinate Li Zhong over and handed him the anti-allergic drug project.

Li Zhong is already the deputy director of the generic drug laboratory and can be considered a middle-level person in the company.

From a junior laboratory technician to being promoted to this position in less than two years, it is indeed a rocket-like rise, which is quite rare in the company.

Since he only had a bachelor's degree, he was unable to contribute to the research and development of new drugs, so he specialized in drug clinical trials and subsequent marketing.

His ability in this area is quite outstanding. All projects are completed very smoothly and he never makes mistakes. Wei Kang also has great trust in him.

Li Zhong smiled honestly, took over the task and left.

*****

Chen Yiqing sat in his office, looking at the animal experiment report in his hand, grinning from the corner of his mouth to the back of his ears.

Pet medicine, the pet medicine he dreams of.

At this moment, when I finally got it, it was like a dream come true.

Ever since he had three cats at home, he has always wanted to work hard in his spare time and develop several useful pet medicines.

God knows how hard he worked, but unfortunately he always failed repeatedly and gained nothing.

Now, finally, a pet medicine has been handed over to him, and it is a specific medicine for cats with terminal diseases that are transmitted from cat to cat. How can he not be ecstatic and excited?

You know, as a senior cat lover, he has always seen the chaos and lack of medication in the pet market and is anxious in his heart.

Pet drugs in China are mostly drugs for treating dog and cat diseases. They are managed by the Ministry of Agriculture and are produced in accordance with veterinary drug GMP standards.

The demand for domestic pet drugs has always been small. Most pet hospitals use human drugs instead, so there are not many professional pet drug companies.

The leading shares of the global pet drug market are highly concentrated, with the top four companies accounting for nearly 40% of the global animal health (animal health) market.

The top ten imported drugs in domestic pet drug sales are basically from Zoetis, Bayer, Boehringer and Merck Animal Health, which is similar to the international pet drug market pattern.

As more and more people keep pets in China, the pet drug market also has broad prospects. The market size is about 5 billion yuan. Judging from the sales of cat and dog food during the annual online shopping festival, this market still has a large With room for growth, it will definitely become a tens of billions market in the next few years.

Many domestic veterinary drug companies have begun to expand into pet drug-related fields, but no large-scale animal health company has yet been formed. Pet drugs are divided into two types, one is common medicines such as anthelmintic drugs, which are mostly purchased and used by pet parents themselves. One is to rely on professional pet hospital sales.

Cat-borne peritonitis, also known as feline infectious peritonitis, is a common RNA virus infectious disease. It is caused by enteritis virus mutation caused by cat stress or low immunity. The onset period is short and the fatality rate is as high as 95%. It is one of the three major diseases in cats. One of the terminal diseases.

Treatment is expensive, and there are no formal specific drugs. Once a cat gets the disease, cat parents may face a double blow of losing money and money.

Among many cat owners, Chen Yiqing has seen countless cats experience great pain and then die tragically in pet hospitals.

Every time he sees someone else's lively and cute cat die, it is also a kind of torture for him.

Now, finally, there is a specific medicine that can completely cure this terminal disease.

Although specific drugs for kidney disease and rickets, two of the three most common terminal diseases in cats, are still far off in sight, Chen Yiqing has full confidence in the company. He believes that with Sanqing’s technology, as long as he is willing to enter the field of pet medicine, he can definitely cure these three terminal diseases.
Chapter completed!